{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/warts-anogenital/","result":{"data":{"firstChapter":{"id":"673e021d-a2fb-52b7-bcd9-3467b771a57f","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 2cfd9df6-894b-4655-a9ef-2bf7eacf179b --><h1>Warts - anogenital: Summary</h1><!-- end field 2cfd9df6-894b-4655-a9ef-2bf7eacf179b -->","htmlStringContent":"<!-- begin item 76e05b34-c291-4ea0-9bde-a3535f888a63 --><!-- begin field 5b728b72-89ac-4545-8b4d-76d9907f684c --><ul><li>Anogenital warts (<em>condylomata acuminata</em>) are benign, proliferative growths occurring in the genital, perineal, anal, and perianal areas.</li><li>Anogenital warts are caused by the human papillomavirus (HPV), most commonly low-risk genotypes 6 and 11.</li><li>In 2015, there were 68,310 newly diagnosed cases of genital warts in England, which accounts for 16% of all cases of newly diagnosed sexually transmitted infections (STIs). <ul><li>There was a 7% decrease in the incidence of newly diagnosed genital warts in England between 2014 and 2015.</li><li>The peak age of prevalence for women is 20–24 years, and 25–34 years for men. </li></ul></li><li>The most common mode of transmission is sexual contact, but anogenital warts may rarely be transmitted peri-natally and from hand warts.</li><li>Diagnosis is usually made on the basis of clinical examination:<ul><li>Lesions may be single or multiple and tend to occur in areas of high friction. </li><li>Warts on dry, hairy skin tend to be firm and keratinized (horny). Those on warm, moist, non–hair-bearing skin tend to be soft and non-keratinized.</li><li>Lesions may be broad-based or pedunculated (attached by a stalk), and some are pigmented.</li></ul></li><li>Assessment of someone suspected of having anogenital warts should include:<ul><li>Taking a brief sexual history to establish the risk of co-existing STIs.</li><li>Asking about the symptoms.</li><li>Examining the external genitalia, and extra-genital sites.</li></ul></li><li>Biopsy should not normally be performed unless the lesions are atypical. </li><li>Other lesions which may be misdiagnosed as anogenital warts include:<ul><li>Pearly penile papules.</li><li>Benign molluscum contagiosum, skin tags, and seborrhoeic keratoses.</li><li>Vulval, penile, or anal intraepithelial neoplasia, and frank malignancy.</li><li>Anogenital condylomata lata of secondary syphilis.</li></ul></li><li>Referral to a sexual health specialist is recommended for all people with anogenital warts, especially: <ul><li>Women who are pregnant. </li><li>Children (the possibility of sexual abuse should be considered).</li><li>People who are immunocompromised (for example HIV).</li></ul></li><li>Referral is essential if:<ul><li>The diagnosis is uncertain.</li><li>Malignancy or intraepithelial neoplasia is suspected.</li><li>The warts are cervical, intrameatal, or intra-anal.</li></ul></li><li>Treatment for anogenital warts should only be offered in primary care if:<ul><li>Referral to a sexual health specialist is declined or unavailable and the diagnosis of external genital warts is certain.</li><li>The skills and resources to provide a comprehensive sexual health service are available.</li></ul></li><li>Treatment options for anogenital warts include:<ul><li>No treatment — one-third of visible warts disappear spontaneously within 6 months.</li><li>Self-applied treatments (podophyllotoxin 0.5% solution, or 0.15% cream, imiquimod 5% cream, sinecatechins 10% ointment). </li><li>Ablative methods (such as cryotherapy, excision, and electrocautery) — these should be considered only if the practitioner is appropriately trained.</li></ul></li><li>In addition:<ul><li>An explanation of the condition and treatment should be given.</li><li>Women should be advised that no changes are recommended in the screening intervals of cervical cytology.</li><li>The use condoms during sexual intercourse should be advised.</li><li>Smoking cessation should be advised, if relevant, to improve response to treatment.</li></ul></li><li>The person's current sexual partner may benefit from assessment for undetected genital warts or other undetected STIs, or for explanation and advice about the disease process in their partner.</li></ul><!-- end field 5b728b72-89ac-4545-8b4d-76d9907f684c --><!-- end item 76e05b34-c291-4ea0-9bde-a3535f888a63 -->","topic":{"id":"e7a3f2d8-5f5c-5ba5-a771-18dfa2a34ece","topicId":"2ff76478-9567-414a-a850-4f9608dd4feb","topicName":"Warts - anogenital","slug":"warts-anogenital","aliases":[],"chapters":[{"id":"673e021d-a2fb-52b7-bcd9-3467b771a57f","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"ac99c8bf-87d2-52a1-8485-e38fee62d2d3","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"7ee801e8-cb99-5752-81b8-62e0d1660af0","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"3ca6914f-3aca-5823-b591-4de01ae58b9d","slug":"changes","fullItemName":"Changes"},{"id":"ca4c177d-14a1-5222-bb51-8c52162b0687","slug":"update","fullItemName":"Update"}]},{"id":"7970a29f-32ff-5788-992e-9a2a02fd909e","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"78ac4b28-280b-5af0-9547-55357fce168f","slug":"goals","fullItemName":"Goals"},{"id":"9b223dc3-5b17-5d5e-a693-4e5c5d7f89a4","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"8c1c2a62-d986-55e6-9131-7eeb96cd8c26","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"d5e6469f-75c7-5a1c-8dea-d31a4c066353","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"d2692bb1-78d5-5ce8-a2c2-252f1f8238ca","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"43a07fd6-910a-5025-a989-3db317b8cd1c","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"98c96f9a-dadf-585b-af6c-70cfbaa769af","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"7a459ab9-55fe-5d56-9c06-35b3447cf0f3","slug":"definition","fullItemName":"Definition"},{"id":"9501b6fc-6ddf-57da-b4a1-0de76a0c7c49","slug":"causes","fullItemName":"Causes"},{"id":"c22bc57c-cdd6-5330-b88f-11aa440a0bd3","slug":"transmission","fullItemName":"Transmission"},{"id":"63eca59f-4ff0-5ce0-a4cb-e893f95d6d40","slug":"prevalence","fullItemName":"Prevalence"},{"id":"67bcb534-24c1-5405-a371-00e3b3234238","slug":"complications","fullItemName":"Complications"},{"id":"9f628e4f-fe37-5c7b-b9b9-68ca563cc306","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"750b2924-a2af-5b82-9d04-8071a886ec8f","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"45d6382a-5bf8-52dc-be32-eca7478a9a0d","slug":"assessment","fullItemName":"Assessment"},{"id":"126f2080-3e60-5a09-a26a-8a13d5e050ea","slug":"signs-symptoms","fullItemName":"Signs and symptoms"},{"id":"a3122ed7-4faf-52d8-8714-99ebcc69d085","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"12587369-d043-546c-adf4-e1e5572741f1","slug":"management","fullItemName":"Management","subChapters":[{"id":"c91156c1-59d1-5b14-8f39-bf08dc3bc8f9","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"f5a42760-c0e3-56e3-b935-d180d409a30e","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"ed0173f4-aefc-569f-81f2-19df322c9290","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"913d974d-9c96-5914-836f-e8e7f72f78b3","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"35560bdc-50e2-5351-9d97-40d6da9f9c18","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"813cc37b-94d6-545a-844e-7d6f84d0e99c","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"fc968029-b704-5091-ba16-92aeefda51c2","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"81cb227a-e86d-54e1-942c-456ae8251dc2","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"c81502ec-60d8-5a69-ad22-46e42e704b95","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"e7a3f2d8-5f5c-5ba5-a771-18dfa2a34ece","topicId":"2ff76478-9567-414a-a850-4f9608dd4feb","topicName":"Warts - anogenital","slug":"warts-anogenital","aliases":[],"topicSummary":"Anogenital warts (condylomata acuminata) are benign, proliferative growths occurring in the genital, perineal, anal, and perianal areas.","lastRevised":"Last revised in April 2017","nextPlannedReviewBy":"2022-05-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2022-04","nextPlannedReviewByDisplay":"April 2022","specialities":[{"id":"e174a859-759f-5b1d-898e-1a4155645e13","name":"Infections and infestations","slug":"infections-infestations"},{"id":"f05d0400-7348-5229-ab3e-400d91618189","name":"Sexual health","slug":"sexual-health"},{"id":"50071c38-ab10-5ab8-ac70-6bd19a96c24e","name":"Skin and nail","slug":"skin-nail"}],"chapters":[{"id":"673e021d-a2fb-52b7-bcd9-3467b771a57f","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"ac99c8bf-87d2-52a1-8485-e38fee62d2d3","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"7ee801e8-cb99-5752-81b8-62e0d1660af0","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"3ca6914f-3aca-5823-b591-4de01ae58b9d","slug":"changes","fullItemName":"Changes"},{"id":"ca4c177d-14a1-5222-bb51-8c52162b0687","slug":"update","fullItemName":"Update"}]},{"id":"7970a29f-32ff-5788-992e-9a2a02fd909e","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"78ac4b28-280b-5af0-9547-55357fce168f","slug":"goals","fullItemName":"Goals"},{"id":"9b223dc3-5b17-5d5e-a693-4e5c5d7f89a4","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"8c1c2a62-d986-55e6-9131-7eeb96cd8c26","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"d5e6469f-75c7-5a1c-8dea-d31a4c066353","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"d2692bb1-78d5-5ce8-a2c2-252f1f8238ca","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"43a07fd6-910a-5025-a989-3db317b8cd1c","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"98c96f9a-dadf-585b-af6c-70cfbaa769af","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"7a459ab9-55fe-5d56-9c06-35b3447cf0f3","slug":"definition","fullItemName":"Definition"},{"id":"9501b6fc-6ddf-57da-b4a1-0de76a0c7c49","slug":"causes","fullItemName":"Causes"},{"id":"c22bc57c-cdd6-5330-b88f-11aa440a0bd3","slug":"transmission","fullItemName":"Transmission"},{"id":"63eca59f-4ff0-5ce0-a4cb-e893f95d6d40","slug":"prevalence","fullItemName":"Prevalence"},{"id":"67bcb534-24c1-5405-a371-00e3b3234238","slug":"complications","fullItemName":"Complications"},{"id":"9f628e4f-fe37-5c7b-b9b9-68ca563cc306","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"750b2924-a2af-5b82-9d04-8071a886ec8f","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"45d6382a-5bf8-52dc-be32-eca7478a9a0d","slug":"assessment","fullItemName":"Assessment"},{"id":"126f2080-3e60-5a09-a26a-8a13d5e050ea","slug":"signs-symptoms","fullItemName":"Signs and symptoms"},{"id":"a3122ed7-4faf-52d8-8714-99ebcc69d085","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"12587369-d043-546c-adf4-e1e5572741f1","slug":"management","fullItemName":"Management","subChapters":[{"id":"c91156c1-59d1-5b14-8f39-bf08dc3bc8f9","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"f5a42760-c0e3-56e3-b935-d180d409a30e","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"ed0173f4-aefc-569f-81f2-19df322c9290","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"913d974d-9c96-5914-836f-e8e7f72f78b3","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"35560bdc-50e2-5351-9d97-40d6da9f9c18","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"813cc37b-94d6-545a-844e-7d6f84d0e99c","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"fc968029-b704-5091-ba16-92aeefda51c2","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"81cb227a-e86d-54e1-942c-456ae8251dc2","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"c81502ec-60d8-5a69-ad22-46e42e704b95","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"e7a3f2d8-5f5c-5ba5-a771-18dfa2a34ece"}},"staticQueryHashes":["3666801979"]}